HLA ‐ matched related donor hematopoietic stem cell transplantation in a patient with polynucleotide kinase 3–phosphatase mutation developed acute myeloid leukemia
- 21 February 2022
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (4) , e14255
Abstract
Background: PNPK gene mutations result in DNA repair disorders and have a spectrum of neurodevelopmental manifestations. To date, cancer predisposition has not been described in patients with PNKP mutations.Observation: Here, we report a patient with PNKP mutation, who developed AML at age of five and underwent reduced‐intensity HSCT.Conclusion: Although many DNA repair disorders are known to have increased risk of malignancy, association between PNKP mutations and malignancy is not well‐described. This report is the first description of a PNPK mutation patient developing a malignancy and undergoing curative HSCT.Keywords
This publication has 15 references indexed in Scilit:
- Mutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4The American Journal of Human Genetics, 2015
- HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabineBlood, 2015
- Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute LeukemiaJournal of Clinical Oncology, 2013
- Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutationsneurogenetics, 2012
- Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repairTrends in Biochemical Sciences, 2011
- Pathophysiology and management of inherited bone marrow failure syndromesBlood Reviews, 2010
- Mutations in PNKP cause microcephaly, seizures and defects in DNA repairNature Genetics, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- HLA-Matched Related Donor Hematopoietic Cell Transplantation in 43 Patients with Fanconi Anemia Conditioned with 60 mg/kg of CyclophosphamideTransplantation and Cellular Therapy, 2007
- The Molecular Architecture of the Mammalian DNA Repair Enzyme, Polynucleotide KinaseMolecular Cell, 2005